IP Library Granted Patent US 9,611,230
Granted Patent B2
US 9,611,230 · App. 11/577,191 · Granted Apr 4, 2017

1,3,4-oxadiazole benzoic acid compounds and their use for nonsense suppression and the treatment of disease

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,611,230
App. No.
11/577,191
Granted
Apr 4, 2017
Kind
B2
Abstract

The present invention relates to methods, compounds, and compositions for treating or preventing diseases associated with nonsense mutations in an mRNA by administering the compounds or compositions of the present invention. More particularly, the present invention relates to methods, compounds, and compositions for suppressing premature translation termination associated with a nonsense mutation in an mRNA.

Claims (15)

1. A compound of Formula 1-A:

wherein:

R 3 is absent;

W is selected from the group consisting of:

wherein when W is selected from the group consisting of:

then

 shown in Formula 1-A is in the meta or para position; and

wherein when W is selected from the group consisting of

then

 shown in Formula 1-A is in the meta position;

and a pharmaceutically acceptable salt of said compound of Formula 1-A, wherein * indicates the only bond of attachment for W, and wherein said bond of attachment is a direct bond of attachment.

2. A compound selected from the group consisting of:

and a pharmaceutically acceptable salt thereof.

3. The compound of claim 2 , wherein said compound is selected from the group consisting of:

and a pharmaceutically acceptable salt thereof.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Jul 14, 2020
From: MIDCAP FINANCIAL TRUST, AS AGENT
To: PTC THERAPEUTICS, INC.
Reel/Frame 053209/0872 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCLUSION OF 6420591,6583309,6503713, 5843995,7029846,7056656, 6468969,6486305,6630294, 6989256,6627398,8247167, 9017935 PREVIOUSLY RECORDED ON REEL 042418 FRAME 0774. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY INTEREST. Recorded Aug 24, 2017
From: PTC THERAPEUTICS, INC.
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 043672/0096 →
SECURITY INTEREST Recorded May 8, 2017
From: PTC THERAPEUTICS, INC.
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 042418/0774 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 17, 2007
From: ALMSTEAD, NEIL G.; CHEN, GUANGMING; KARP, GARY M.; WELCH, ELLEN; WILDE, RICHARD; CAMPBELL, JEFFREY A.
To: PTC THERAPEUTICS, INC.
Reel/Frame 019972/0902 →